A review of formulations of commercially available antibodies

Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans

(2021) Galen H. Shi et al.   AAPS PHARMSCITECH

Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association

(2019) Chaitanya M. Sudrik et al.   PHARMACEUTICAL RESEARCH

Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecan

(2019) David M. Goldenberg et al.   mAbs

Physicochemical Stability of Monoclonal Antibodies: A Review

(2019) Yoann Le Basle et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Hold the device against the skin: the impact of injection duration on user’s force for handheld autoinjectors

(2019) Andreas Schneider et al.   Expert Opinion on Drug Delivery

Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities

(2018) Beate Bittner et al.   BIODRUGS

How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions

(2017) Maarten A. Mensink et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery

(2016) Diane V. Doughty et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers

(2015) Thomas M. Cardillo et al.   BIOCONJUGATE CHEMISTRY

Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications

(2015) Sven Bahrenburg et al.   Biotechnology Journal

Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies

(2015) Shujing Wang et al.   MOLECULAR PHARMACEUTICS

Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications

(2015) Sven Bahrenburg et al.   Biotechnology Journal

Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in Rats

(2011) Leonid Kagan et al.   PHARMACEUTICAL RESEARCH

High-Throughput Screening of Excipients Intended to Prevent Antigen Aggregation at Air-Liquid Interface

(2011) Sébastien Dasnoy et al.   PHARMACEUTICAL RESEARCH

A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis

(2008) Amer Jaber et al.   BMC Neurology

Reversible Self-Association of a Concentrated Monoclonal Antibody Solution Mediated by Fab–Fab Interaction That Impacts Solution Viscosity

(2008) Sonoko Kanai et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Self-Buffering Antibody Formulations

(2007) Yatin R. Gokarn et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways

(2007) Bruce A. Kerwin   JOURNAL OF PHARMACEUTICAL SCIENCES